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ing multiple academic programs. Using ASRS-v1.1 symptom cut-off threshold, a 
prevalence rate of ADHD symptoms ranging from 21.2% to 66.2% (indicating likeli-
hood and immense likelihood of ADHD respectively) was observed for the general 
student sample. Only 3.4% of the participants had been previously diagnosed with 
ADHD. The prevalence of self-reported ADHD symptoms was higher in the age group 
of 18-23 years (81.3%) and was greater in females (53.1%). A majority of students 
had the inattentive type of symptomatology (72.72%). With regard to different 
disciplines, prevalence rates ranged from 49% (pharmacy school) to 5.9% (school 
of education). More undergraduate students reported AADHD symptoms (70.9%) 
compared to graduate students (28.4%). Students in healthcare discipline reported 
greater ADHD symptomatology (54.6%) compared to students in non-healthcare 
fields. CONCLUSIONS: Symptoms of AADHD appear to be more prevalent in stu-
dent populations than documented evidence would suggest. Among many that are 
affected, most are either unaware of the condition or undiagnosed. These findings 
have implications for students’ overall health and academic performance.
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OBJECTIVES: Given considerable variability in treatment response and medication 
side effects across individual patients using antipsychotics, customizing treatment 
to the needs of each individual is key to improving patient outcomes. This study 
examined the degree to which psychiatrists were diversified vs. concentrated in 
their choice of antipsychotic medication and identified factors associated with 
their prescribing. METHODS: Using 2011 data from Pennsylvania’s Medicaid we 
identified psychiatrists who regularly prescribed antipsychotics (defined as ≥ 10 
nonelderly patients). Using prescriber ID we linked claims data, from which we 
obtained information on patient characteristics and psychiatrist prescribing behav-
ior, to demographic information on psychiatrists from the AMA Masterfile, and to 
information on organizational affiliations from IMS Health’s HCOS TM database. 
We used three measures of antipsychotic prescribing concentration: Herfindahl 
index (HHI), share of most preferred ingredient, and number of ingredients. We 
used multiple membership linear mixed models to evaluate the degree of con-
centration for antipsychotic prescribing. Predictors included patient-, physician-, 
and organization-level factors. RESULTS: The analytic cohort included 764 psychia-
trists treating 65,256 patients. Psychiatrists prescribed several ingredients (mean: 
9); however, prescribing behavior was relatively concentrated (mean HHI: 2,603; 
share of most preferred ingredient: 37.8%), with wide variation across psychiatrists 
(range HHI: 1,088-7,270; share of most preferred ingredient: 16.4%-84.7%; number 
of ingredients: 2-17). Having a higher share of SSI-eligible patients, patients with 
serious mental illnesses, non-Hispanic whites, and older patients was associated 
with less concentrated prescribing although effects were relatively small (all p< .05). 
Female psychiatrists had more concentrated prescribing than that of their male 
counterparts (p< .10). Psychiatrists affiliated with behavioral health organizations 
had more diversified antipsychotic prescribing. CONCLUSIONS: Antipsychotic pre-
scribing behavior in a large state Medicaid program was relatively concentrated 
and varied substantially across psychiatrists. Some psychiatrists treating Medicaid 
enrollees with antipsychotics may be limited in their ability to tailor treatment to 
individual patient needs and preferences.
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OBJECTIVES: Kentucky House Bill 1 (HB1) was enacted in July 2012 to address pre-
scription drug abuse and diversion. This legislation included stronger pain clinic 
regulations, mandatory prescriber registration with Kentucky’s prescription drug 
monitoring program (PDMP) and mandatory use of PDMP data prior to issuing a 
new controlled substance prescription. The purpose of this study was to assess 
the impact of HB1 on the concurrent prescribing of three controlled substances: 
an opioid (hydrocodone or oxycodone), alprazolam, and carisoprodol (OAC). This 
combination has been identified as a signal for misuse and diversion. METHODS: 
De-identified PDMP data from July 2009 through June 2013 was analyzed to deter-
mine the number of patients who concurrently received prescriptions for OAC. 
Concurrent was defined as receiving prescriptions for each OAC component within 
30 days. 12-month OAC totals were compared for each fiscal year (defined in KY as 
July 1 – June 30). Fiscal years were chosen for analysis based on the date of imple-
mentation of legislation (July 2012). Differences in mean number of patients receiv-
ing concurrent OAC prescriptions were analyzed using two-tailed t-tests for fiscal 
years pre and post legislation. RESULTS: The number of patients receiving concur-
rent OAC prescriptions for OAC during the study period were 22,423 (FY2010), 25,465 
(FY2011), 22,795 (FY2012), and 15,983 (FY2013). The number of patients receiving 
concurrent OAC prescriptions was significantly lower (P< 0.001) in FY2013 relative 
to FY2012. CONCLUSIONS: Implementation of Kentucky House Bill 1 was associ-
ated with a 29.9% decrease in the concurrent prescribing of a combination of CS 
commonly associated with misuse and diversion. Further studies to differentiate 
the relative impact of pain clinic regulations from the impact of mandatory regis-
tration and use legislation are warranted to determine the effectiveness of these 
approaches in curbing the abuse and diversion of prescription drugs.
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than low volume prescribers. Primary care providers were substantially less likely 
than psychiatrists to prescribe clozapine (OR = 0.55, p< 0.01) but just as likely to 
antipsychotic polypharmacy. CONCLUSIONS: Antipsychotic polypharmacy is used 
as much as clozapine in the care of Medicaid beneficiaries with schizophrenia, but 
many prescribers only use the former. Clinical and policy initiatives are needed to 
improve providers’ knowledge of clozapine and increase its use while decreasing 
use of antipsychotic polypharmacy.
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OBJECTIVES: To examine prevalence rates and co-relates of non-medical use of 
prescription stimulants for attention-deficit-hyperactivity disorder (ADHD) in a uni-
versity student population with respect to student demographics and academic 
characteristics. METHODS: A cross-sectional research design, utilizing a conveni-
ence sampling and self-administered paper and pencil questionnaire technique, 
was adopted. The survey consisted of a screening tool to measure symptoms of 
Adult ADHD Self-Report Scale (ASRS-v1.1) in conjunction with items to measure the 
extent of self-reported prescription drug abuse among students. The use of prescrip-
tion stimulants was profiled for students representing different schools and aca-
demic programs and reasons for the nonmedical use were documented. RESULTS: A 
sample of 638 completed surveys (response rate= 98.15%) was obtained with data on 
unauthorized use of prescription drugs. About 8.62% (N= 55) of the sample reported 
a current and past use of drugs such as Adderall, Ritalin, Dexedrine, Concerta, Cylert 
at least once. Of these, 76.9% used the drugs non-medically for enhancing academic 
performance and 23.1% used them for increasing alertness. The illicit drug usage 
was higher in the age group 18-23 years (87.2%) and was greater for males (64.1%). 
Overall, students from pharmacy school reported highest abuse (46.2%), followed 
by law school (20.5%), school of professional studies (12.8%) and business school 
(10.3%). Generally, undergraduate students reported greater use of prescription 
stimulants (69.2%) compared to graduate students (30.8%). A majority (66.7%) of 
the students were also attending professional degree programs. CONCLUSIONS: 
The current campus estimates are mostly in line with the national statistics (4.1% 
to 10.8%, according to the Center for Lawful Access and Abuse Deterrence, CLAAD, 
2013). Misuse and abuse of prescription stimulants among students is a growing 
problem and largely remains unaddressed. Development of campus educational 
tools to prevent sharing of prescription drugs and guidelines to recognize early 
warning signs to curb abuse are necessary.
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OBJECTIVES: Doctor shopping is a principle method of obtaining controlled sub-
stances (CS) for misuse and is an indicator of escalating drug abuse and fatal over-
dose. Currently, numerical thresholds are used to identify doctor shoppers, but 
a lack of consensus on criteria has led to wide variations in estimated rates. The 
goal of this study was to investigate the feasibility of using social network analy-
sis (SNA) to improve the specification and predictive validity of doctor shopping 
indicators. METHODS: i3 Innovus InVision™ data for the year 2009 was used to 
identify doctor shoppers using the 4 CS (opioid or benzodiazepine) prescriptions 
+ 4 pharmacies criterion. A network of physicians was created using indirect ties 
defined by co-prescription to the same doctor shopping patient. A visualization of 
the clinician network was created to assess clustering, and bivariate analyses were 
conducted to assess the relationship between physician centrality, or number of ties 
to other prescribers through a common doctor shopping patient, in the co-prescrib-
ing network and average characteristics of a physician’s patients. RESULTS: A total 
of 89,297 clinicians prescribed an opioid or benzodiazepine to at least one doctor 
shopper. The mean degree of centrality was 23.15 (SD 61.48 and ranged from 0-995). 
Physician degree centrality is positively correlated with patients’ average number 
of pharmacies (r= .28, p< .001), number of prescriptions (r= 0.21, p< .001), number of 
MPEs (r= 0.43; p< .001), and number of repeated visits to the same prescriber (r= 0.13, 
p< .001). The network visualization map revealed a large network of 7,288 doctors 
tied by 45,181 co-prescribing relationships. CONCLUSIONS: The results of this study 
confirm the feasibility of using SNA to identify doctor shoppers. Further studies 
using two-mode SNA are warranted to improve the specification and predictive 
validity of doctor shopping indicators and to determine the patient, clinician, and 
point-of-service characteristics associated with doctor shopping behavior.
PMH74
Prevalence of self-rePorTed adulT adHd syMPToMs aMong 
universiTy sTudenTs: a MulTidisciPlinary coMParison
Shanbhag P.P., Nayak R.
St. John’s University, Jamaica, NY, USA
OBJECTIVES: To estimate prevalence of Adult ADHD (AADHD) symptoms among uni-
versity-based students across multiple academic disciplines. METHODS: A cross-
sectional research design, utilizing convenience sampling and self-administered 
paper and pencil questionnaire technique, was adopted. Adult students (> 18 years) 
were recruited from a university campus in New York City area. AADHD Self-Report 
Scale- v1.1 (ASRS v1.1), a pre-validated screening instrument, was used to assess 
performance along inattention, hyperactivity/impulsivity and combined symptom 
sets of adult ADHD. A score of 17 or more on an ASRS v1.1 scale between 0 and 72 
indicates the likelihood of ADHD, whereas a score of 24 or more indicates immense 
likelihood of ADHD. Individual component scores of ASRS were compared for stu-
dents from six different schools and programs within the university. RESULTS: 
The final sample consisted of 638 students from six different schools represent-
